Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biogen Pays $1.25bn For Peace Of Mind Over Tecfidera, But Legal Wrangling Continues

Jan 18 2017

• By Sukaina Virji and Michael Cipriano

Related Content

‘Between A Rock And A Hard Place,’ Court Issues Injunction To Halt Praluent Sales

Jan 06 2017

Will $2.5Bn Jury Verdict Against Gilead Stand? Future Royalties, Willful Infringement Penalty Uncertain

Dec 16 2016

CRISPR Companies Form Pact To Defend, Cross-License Gene Editing Patents

Dec 17 2016

Related Companies

Biogen, Inc.

Forward Pharma A/S

Gilead Sciences, Inc.

Merck & Co., Inc.

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Additional Topics

Commercial Legal Issues Neurology BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.